Senior insider sale
TRANSPHORM, INC. — senior position signals high conviction
$32.0K
10.83K shares
What this filing means
SMALES KELLY plans to sell 10.83K shares of TRANSPHORM, INC. valued at approximately $32.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/4/2024ACC: 0001970051-24-000003
10.83K
Shares to sell
$32.0K
Approx. market value
766.00
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Common Stock
COMPENSATORY PAYMENT
1/4/2024
766.00Total acquired766.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/4/2024 | Common Stock COMPENSATORY PAYMENT | 766.00 | — |
| Total | 766.00 | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
2.19K
Market value
$7.9K
1/2/2024
—Completed
Units to sell
4K
Market value
$10.5K
11/22/2023
—Completed
Units to sell
656.00
Market value
$1.9K
11/20/2023
—Completed
Units to sell
3.23K
Market value
$8.8K
11/17/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
766.00
Market value
$3.0K
1/4/2024
Total
Units
10.83K
Value
$32.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/2/2024 | 2.19K | $7.9K | — | Completed |
11/22/2023 | 4K | $10.5K | — | Completed |
11/20/2023 | 656.00 | $1.9K | — | Completed |
11/17/2023 | 3.23K | $8.8K | — | Completed |
| Planned — Approximate Date | ||||
1/4/2024 | 766.00 | $3.0K | NASDAQ | Planned |
| Total | 10.83K | $32.0K | ||